Speak To An Expert
Get clear, personalised advice for your situation.
Jot down a few questions to make the most of your conversation.
How common is mitochondrial disease in the UK?
Mitochondrial disease is considered rare, but it is probably more common than many people realise. In the UK, experts estimate that around 1 in 5,000 people may be affected by a clinically significant mitochondrial disease. That means thousands of children and adults could be living with the condition.
The exact number is hard to pin down. Mitochondrial disease is not one single illness, and it can affect different organs in different ways. Because symptoms can be varied and overlap with other conditions, some people are diagnosed late or not at all.
Why the numbers are difficult to measure
One reason mitochondrial disease is hard to count is that it can look very different from person to person. Some people have mild symptoms, while others become very unwell. It may affect the muscles, brain, heart, eyes, hearing, or digestive system.
There is also no single test that identifies every case. Diagnosis may involve blood tests, genetic testing, scans, muscle biopsies, and specialist assessment. In the past, many cases were likely missed because awareness was lower and testing was more limited.
Who can be affected?
Mitochondrial disease can affect both children and adults. Some people are born with it, while others develop symptoms later in life. It can be inherited from the mother, passed down through the family in different ways, or occur because of a new genetic change.
Although it is rare overall, it is not unusual in specialist clinics to see several families affected by it. Some people may have only one mild symptom, while others have more complex health needs. This wide range makes the condition harder to recognise in everyday NHS care.
What does “rare” mean in practice?
In the UK, a disease is usually classed as rare if it affects fewer than 1 in 2,000 people. Mitochondrial disease fits into this category, but within rare diseases it is one of the more commonly diagnosed groups. Some estimates suggest it may be as common as certain better-known inherited disorders.
This matters because rarity does not mean it is insignificant. Mitochondrial disease can have a major impact on daily life, education, work, and family planning. A condition may be rare in the general population but still affect many families across the country.
Why awareness matters
Greater awareness can help people get a diagnosis sooner. Early recognition may not cure mitochondrial disease, but it can lead to better symptom management, genetic counselling, and the right specialist support. It can also help families understand the risk to relatives.
If you are concerned about possible symptoms, speak to a GP and ask whether referral to a specialist is needed. Common signs can include fatigue, muscle weakness, exercise intolerance, seizures, developmental delay, or repeated unexplained illness. Because the condition is uncommon, specialist advice is often important.
Frequently Asked Questions
Mitochondrial disease prevalence is the proportion of people in a population who are living with a mitochondrial disease at a given time or over a specified period.
Mitochondrial disease prevalence is generally considered low, but estimates vary because these disorders are rare, underdiagnosed, and sometimes difficult to classify consistently across studies.
Mitochondrial disease prevalence varies between studies because of differences in case definitions, diagnostic methods, age groups, genetic testing access, and whether researchers measure point prevalence or lifetime prevalence.
Mitochondrial disease prevalence is measured by counting how many people in a defined population have a mitochondrial disease and dividing that number by the total population, often expressed per 100,000 people.
Mitochondrial disease prevalence can appear different in children and adults because some severe forms present early in life, while other genetic forms are diagnosed later, especially as testing becomes more available.
Mitochondrial disease prevalence may differ by sex for certain mitochondrial disorders, but many forms affect all sexes, and observed differences can reflect inheritance patterns, diagnosis rates, and study design.
Factors influencing mitochondrial disease prevalence estimates include diagnostic criteria, genetic testing availability, awareness among clinicians, inclusion of mild cases, and the quality of population data.
Mitochondrial disease prevalence rates may appear to increase over time as awareness improves, genetic testing expands, and more people with previously unrecognized disease are diagnosed.
Genetic testing can raise measured mitochondrial disease prevalence by identifying people with milder or atypical disease who might otherwise have gone undiagnosed.
Mitochondrial disease prevalence is often thought to be underreported because symptoms can be nonspecific, overlap with other conditions, and require specialized testing for confirmation.
Mitochondrial disease prevalence refers to how many people currently live with the disease, while incidence refers to how many new cases are diagnosed within a specific time period.
The contribution to mitochondrial disease prevalence depends on the population studied, but common pathogenic variants and syndromes such as those involving mitochondrial DNA mutations often account for a substantial share of recognized cases.
Mitochondrial disease prevalence by age at diagnosis varies because some disorders are recognized in infancy, while others are not diagnosed until adolescence or adulthood due to slower symptom progression.
In rare disease research, mitochondrial disease prevalence is often reported as uncommon but not vanishingly rare, with estimates differing widely based on the population, methods, and whether nuclear or mitochondrial genetic causes are included.
Mitochondrial disease prevalence is difficult to estimate accurately because symptoms are diverse, diagnosis may require advanced testing, and many patients remain unrecognized or are misclassified under other neurologic or metabolic conditions.
Newborn screening programs can influence mitochondrial disease prevalence estimates by identifying affected infants earlier, but most mitochondrial diseases are not universally included in routine newborn screening.
Yes, mitochondrial disease prevalence can differ across countries because of differences in genetics, healthcare access, diagnostic resources, reporting systems, and population structure.
Family history studies can increase understanding of mitochondrial disease prevalence by identifying relatives at risk and revealing clusters of disease that may not be captured in general population estimates.
Researchers typically report mitochondrial disease prevalence as a rate or percentage, often with confidence intervals, and may specify whether the estimate is point prevalence, period prevalence, or lifetime prevalence.
Improved awareness matters for mitochondrial disease prevalence because clinicians who recognize the signs are more likely to order appropriate testing, leading to more complete and accurate case identification.
Useful Links
Ergsy Search Results
This website offers general information and is not a substitute for professional advice.
Always seek guidance from qualified professionals.
If you have any medical concerns or need urgent help, contact a healthcare professional or emergency services immediately.
Some of this content was generated with AI assistance. We've done our best to keep it accurate, helpful, and human-friendly.
- Ergsy carefully checks the information in the videos we provide here.
- Videos shown by Youtube after a video has completed, have NOT been reviewed by ERGSY.
- To view, click the arrow in centre of video.
- Most of the videos you find here will have subtitles and/or closed captions available.
- You may need to turn these on, and choose your preferred language.
- Go to the video you'd like to watch.
- If closed captions (CC) are available, settings will be visible on the bottom right of the video player.
- To turn on Captions, click settings.
- To turn off Captions, click settings again.